Mariano, Rosalie .

HRN: 14-31-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
CEFUROXIME 500MG (TAB)
05/29/2023
06/05/2023
PO
500mg
BID X 7days
Thickly MSAF
Waiting Final Action 
05/29/2023
METRONIDAZOLE 500MG (TAB)
05/29/2023
06/05/2023
PO
500mg
TID X 7days
Thickly MSAF
Waiting Final Action 
05/29/2023
CEFUROXIME 1.5GM (VIAL)
05/29/2023
06/05/2023
IV
1.5g
Q8 ANST
Wbc: 30.9; IUFD; S/P NSVD
Waiting Final Action 
05/31/2023
CEFUROXIME 500MG (TAB)
05/31/2023
06/07/2023
PO
500mg
BID X 7 Days
S/P NSVD To Stillborn Neonate; Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: